Cortechs.ai | Cortechs.ai announces distribution partnership with EnvoyAI

Cortechs.ai announces distribution partnership with EnvoyAI

NeuroQuant is now available on EnvoyAI’s artificial intelligence Exchange.

Cortechs.ai, the leading medical software innovator providing solutions for quantitative brain volume analysis, is pleased to announce a distribution agreement with EnvoyAI, the leading artificial intelligence (AI) Exchange platform. NeuroQuant® and its LesionQuant™ module, Cortechs.ai’ leading MR image post-processing solutions, which expand physicians’ resources for assessing and quantifying brain structure and lesion volumes, is now available for purchase on the EnvoyAI Exchange.

Cortechs.ai solutions provide valuable, automated, quantitative data on brain structures and lesions, aiding radiologists in providing supportive information to neurologists and other healthcare professionals.  The solutions enhance clinical assessments, treatment planning, and disease progression monitoring of patients with neurological conditions, such as Alzheimer’s disease, epilepsy, multiple sclerosis, traumatic brain injury and more.

“We are entering an era of quantitative image analysis and EnvoyAI is excited to have Cortechs.ai’ FDA cleared quantitative imaging algorithms available through our Exchange,” said Dr. Steven Rothenberg, Chief Medical Officer at EnvoyAI. “Providing automated and objective measurements of brain structure volumes allows radiologists to provide more thorough assessments for patients and more complete reporting for referring physicians.”

“We are extremely pleased to partner with EnvoyAI and participate on their Exchange to provide access to quantitative imaging algorithms and data,” said Guri Stark, CEO of Cortechs.ai. “Over the last few years, NeuroQuant has become the standard for brain volume measurements. EnvoyAI increases the reach and impact of these algorithms to enhance healthcare globally.”

###

Contact: Travis Foegler
Phone: +1 (619) 450-9094
Email: Tfoegler@cortechs.ai

More Resources

05/18/2025

Cortechs.ai and ALZ-NET Announce Strategic Collaboration to Improve Alzheimer’s Disease Care Through AI-Driven Imaging

This new strategic collaboration aims to enhance the quality of care for people living with Alzheimer’s disease.

05/16/2025

Case Study: NeuroQuant® for ARIA: Monitoring ARIA Progression in Early Alzheimer’s Disease

Dr. Suzie Bash highlights how advanced imaging with NeuroQuant for ARIA supported detection and monitoring of ARIA-E and ARIA-H in an 81-year-old patient.

05/13/2025

Dr. Ana M. Franceschi Joins Cortechs.ai Medical Advisory Board

Neuroimaging thought leader to enhance PET/MRI and dementia research impact through AI-powered tools

05/10/2025

All the Ways to Use the NeuroQuant Custom Report

With the ability to select structures from NeuroQuant’s 70+ structure parcellation atlas, the user has the power to truly personalize patient care!

05/04/2025

Introducing NeuroQuant MS Lesion Dynamics Computation: A Clearer Path to Understanding Disease Progression

Discover how the latest NeuroQuant MS update offers a clearer, more intuitive way to track lesion changes and understand disease progression over time.

05/02/2025

4 Reasons Why Over 1500 Medical Centers Worldwide Trust Cortechs.ai

Trusted by 1500+ medical centers, Cortechs.ai delivers AI-powered imaging tools that enhance diagnostic accuracy and streamline workflows.
Scroll to Top